vertical-ai

5 items

The Wall Street Journal 2026-05-26-3

AI Expands From Multibillion-Dollar Enterprises to Main Street

The WSJ writeup of an $8M bakery running a bespoke AI ERP at a few hundred dollars a month buries its actual lede: the consultant, a firm called Streamliners, is the entire delivery layer, and the foundation-model vendor goes unnamed in a 1,200-word feature. At sub-$10M revenue scale, the harness-as-moat thesis operationalizes as consultant-as-moat: $300/mo in MRR goes to the builder, a few dollars in API credits go to Anthropic or OpenAI. The buried operator quote, "you have to build guardrails in so it's not deciding to make 20,000 cakes on Monday," names the next unoccupied category: eval-and-guardrail-as-a-service for the 5,000-plus Streamliners-equivalents forming through 2027.

NBC News · 2026-05-14 2026-05-15-w2

OpenEvidence: Most physicians quietly use this medical AI tool

OpenAI launched ChatGPT for Clinicians in April without licensing NEJM or JAMA. OpenEvidence has both, and the market repriced it from $1B to $12B in 15 months on the back of 65% US physician reach and 27 million April clinical encounters. The binding constraint for entering credentialed verticals was never model quality; it was licensed-data governance and the operational-regime approval that comes with it. The Deployment Company and the LF Networking pattern this week are structurally identical: the moat that holds isn't capability, it's the layer of credential, distribution, or implementation sitting above it. For frontier labs, that means the verticals with the clearest content-licensing moats (clinical, legal, financial) will reprice fastest against whoever shows up without the corpus.

NBC News 2026-05-14-2

OpenEvidence: Most physicians quietly use this medical AI tool

OpenAI launched ChatGPT for Clinicians in April without licensing NEJM or JAMA. OpenEvidence has both, hit 65% of US physicians across 27 million April clinical encounters, and got repriced from $1B to $12B in 15 months. The binding constraint for frontier labs entering credentialed verticals is content licensing, not model capability, and OpenAI just supplied the revealed-preference proof.

Financial Times 2026-05-05-2

'It's crucial': how AI is reshaping the fragrance industry

Givaudan, Symrise, and dsm-firmenich spent eight years building proprietary ingredient databases with AI tooling now in production at the world's largest consumer brands, and they still trade on commodity-chemistry multiples. Moodify's ML-driven formulation compresses the canonical 18-month development cycle to three months at 30% lower cost; FoodPairing's digital consumer panels hit 77% accuracy against real panels — a direct shot at a $50B+ research industry that gets no equity-market scrutiny. The frontier-lab-doesn't-verticalize pattern is now four verticals deep and priced in nowhere.

New York Magazine — Intelligencer 2026-04-28-2

My Adventures Setting Up an OpenClaw Agent

Sam Altman, Jensen Huang, and Andrej Karpathy called OpenClaw the most important software ever shipped; three months later an NY Mag columnist burned $8 of $30 in API credits during setup, found no sticky use case across six workflows, and uninstalled — while Claude Cowork connected to Drive, analyzed a bank statement stack, and shipped a school-deadline widget in the same session. What the comparison isolates isn't model capability; it's embedded versus standalone. Consumer agents that require their own surface are acqui-hire candidates; the ones that win will be ambient features inside apps people already open, which is exactly what Anthropic restricting OpenClaw access and Altman hiring its founder both signal.

⟷ links
art_20260428_tinkerslop-and-the-use-case-discovery-faart_20260428_whitespace-vertical-closed-agent-apps-foart_20260404_anthropic-bans-openclaw-from-claude-subsart_20260413_building-agents-at-home-consumer-agent-aart_20260412_sundar-pichai-on-ai-at-google-vertical-i2026-04-04-32026-04-04-22026-04-01-22026-04-15-22026-03-09-32026-04-10-w12026-04-09-22026-03-22-22026-04-07-22026-04-08-12026-04-17-22026-04-22-12026-04-23-12026-04-22-3